They Work—But Barely
2:43–3:29 · 46s
Tara Spires-Jones explains that lecanemab and donanemab do remove brain amyloid and slow decline, but the benefits are small and come with risks like rare brain swelling or bleeding.
2:43–3:29 · 46s
Tara Spires-Jones explains that lecanemab and donanemab do remove brain amyloid and slow decline, but the benefits are small and come with risks like rare brain swelling or bleeding.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.